674 research outputs found

    Temporal and Spectral Properties of the Persistent Radio Source Associated with FRB 20190520B with the VLA

    Full text link
    Among more than 800 known fast radio bursts (FRBs), only two, namely FRB 20121102A and FRB 20190520B, are confirmed to be associated with a persistent radio sources (PRS). Here we report evidence of apparent temporal variability in the PRS associated with the bursting FRB 20190520B based on the Karl G. Jansky Very Large Array (VLA) observations taken in 2020 and 2021. Based on the analysis of epoch-to-epoch variability of the PRS at L, S, C, and X band in 1-12 GHz, we detected not only overall marginal variability but also a likely radio flux decrease (∌\sim 3.2 σ\sigma) between the observations taken in 2020 and 2021 at 3 GHz. Assuming no spectral variation in the PRS during these observations, we found the evidence for an overall broadband radio flux decrease by about 20 percent between the 2020 and the 2021 observations, suggesting that the PRS probably evolves on the yearly time scale. If we attribute the marginal variability at 3 GHz as intrinsic or due to scintillation, the size of potential variable component of the PRS is constrained to be sub-parsec. On the other hand, the size of the PRS can be also constrained to be larger than about 0.22 parsec from the averaged radio spectrum and the integrated radio luminosity in the 1-12 GHz band based on equipartition and self-absorption arguments. We discuss potential origins of the PRS and suggest that an accreting compact object origin might be able to explain the PRS's temporal and spectral properties. Confirmation of variability or flux decline of the PRS would be critical to our understanding of the PRS and its relation to the bursting source.Comment: 12 pages, 3 figures, accepted for publication in Ap

    Renal venous sampling assisted the diagnosis of juxtaglomerular cell tumor: a case report and literature review

    Get PDF
    Juxtaglomerular cell tumor (JCT) is an endocrine tumor marked by elevated renin levels and high blood pressure. This case report presents the clinical findings of a 47-year-old woman with a history of recurrent hypokalemia, headaches, hypertension, and increased plasma renin activity (PRA). Dynamic enhanced magnetic resonance imaging (MRI) revealed a small nodule on the upper part of the right kidney. Selective renal venous sampling indicated a higher PRA only in the right upper pole renal vein. The patient underwent surgical removal of the right kidney mass, and the pathology results confirmed the diagnosis of JCT. This case underscores the importance of conducting selective renal venous sampling for accurate JCT diagnosis

    Lycopene Enhances Antioxidant Enzyme Activities and Immunity Function in N-Methyl-Nâ€Č-nitro-N-nitrosoguanidine–Induced Gastric Cancer Rats

    Get PDF
    To investigate anticancer effect of lycopene, we examined the effects of lycopene on the oxidative injury and immunity activities of N-methyl-Nâ€Č-nitro-N-nitrosoguanidine (MNNG)-induced gastric cancer rats. The animals were divided into five groups. Group I served as the normal control and was given corn oil orally for 20 weeks. Group II were induced with MNNG 200 mg/kg body weight by oral gavage at days 0 and 14, and saturated NaCl (1 mL per rats) was given once every three days for four weeks until the end of the experimental period. Group III, IV and V were posttreated with lycopene (50, 100 and 150 mg/kg body weight, dissolved in corn oil) from the sixth week of MNNG (as in group II) induction up to the end of the experimental period. In the presence of MNNG, MDA and immunity levels were significantly increased, whereas enzymatic (SOD, CAT, and GPx) antioxidant activities were decreased in the treated rats compared with normal control rats. Administration of lycopene to gastric carcinoma-induced rats largely up-regulated the redox status and immunity activities to decrease the risk of cancer compared to group II. We conclude that up-regulation of antioxidants and immunity by lycopene treatment might be responsible for the anticancer effect in gastric carcinoma

    Liddle syndrome misdiagnosed as primary aldosteronism resulting from a novel frameshift mutation of SCNN1B

    Get PDF
    Liddle syndrome (LS), a monogenetic autosomal dominant disorder, is mainly characterized by early-onset hypertension and hypokalemia. Clinically, misdiagnosis or missing diagnosis is common, since clinical phenotypes of LS are variable and nonspecific. We report a family with misdiagnosis of primary aldosteronism (PA), but identify as LS with a pathogenic frameshift mutation of the epithelial sodium channel (ENaC) ÎČ subunit. DNA samples were collected from a 32-year-old proband and 31 other relatives in the same family. A designed panel including 41 genes associated with monogenic hypertension was screened using next-generation sequencing. The best candidate disease-causing variants were verified by Sanger sequencing. Genetic analysis of the proband revealed a novel frameshift mutation c.1838delC (p.Pro613Glnfs*675) in exon 13 of SCNN1B. This heterozygous mutation involved the deletion of a cytosine from a string of three consecutive cytosines located at codons 612 to 613 and resulted in deletion of the crucial PY motif and elongation of the ÎČ-ENaC protein. The identical mutation was also found in 12 affected family members. Amiloride was effective in alleviating LS for patients. There were no SCNN1A or SCNN1G mutations in this family. Our study emphasizes the importance of considering LS in the differential diagnosis of early-onset hypertension. The identification of a novel frameshift mutation of SCNN1B enriches the genetic spectrum of LS and has allowed treatment of this affected family to prevent severe complications

    Impact of genital warts on health related quality of life in men and women in mainland China: a multicenter hospital-based cross-sectional study

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Information on the health-related quality of life (HRQoL) of patients with genital warts (GW) in populations in mainland China is still limited. The aim of the study was to use a generic instrument to measure the impact of genital warts on HRQoL in men and women in this setting.</p> <p>Methods</p> <p>A multi-centre hospital-based cross-sectional study across 18 centers in China was conducted to interview patients using the European quality of life-5 dimension (EQ-5D) instrument; respondents' demographic and clinical data were also collected.</p> <p>Results</p> <p>A total of 1,358 GW patients (612 men, 746 women) were included in the analysis, with a mean age of 32.0 ± 10.6 years. 56.4% of the patients reported some problems in the dimension of Anxiety/Depression (highest), followed by Pain/Discomfort (24.7%) and Mobility (3.5%). The overall visual analogue scale (VAS) score of the study population was found to be 65.2 ± 22.0, and the EQ-5D index score was found to be 0.843 ± 0.129 using Japanese preference weights (the Chinese preference was unavailable yet). Patients with lower VAS means and EQ-5D index scores were more often female, living in urban area, and suffering multiple GW (all p values < 0.05), but the values did not differ notably by age (p values > 0.05).</p> <p>Conclusions</p> <p>The HRQoL of patients with GW was substantially lower, compared to a national representative general population in China (VAS = ~80); the findings of different subgroups are informative for future GW prevention and control efforts.</p

    Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study

    Get PDF
    Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≄ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe

    Observation and branching fraction measurement of the decay Ξb- → Λ0 bπ -

    Get PDF

    Measurement of ZZ boson production cross-section in pppp collisions at s=5.02\sqrt{s} = 5.02 TeV

    Get PDF
    The first measurement of the ZZ boson production cross-section at centre-of-mass energy s=5.02 \sqrt{s} = 5.02\,TeV in the forward region is reported, using pppp collision data collected by the LHCb experiment in year 2017, corresponding to an integrated luminosity of 100±2 pb−1100 \pm 2\,\rm{pb^{-1}}. The production cross-section is measured for final-state muons in the pseudorapidity range 2.020 GeV/c2.0 20\,\rm{GeV/}\it{c}. The integrated cross-section is determined to be σZ→Ό+Ό−=39.6±0.7 (stat)±0.6 (syst)±0.8 (lumi) pb \sigma_{Z \rightarrow \mu^{+}\mu^{-}} = 39.6 \pm 0.7\,(\rm{stat}) \pm 0.6\,(\rm{syst}) \pm 0.8\,(\rm{lumi}) \ \rm{pb} for the di-muon invariant mass in the range 60<MΌΌ<120 GeV/c260<M_{\mu\mu}<120\,\rm{GeV/}\it{c^{2}}. This result and the differential cross-section results are in good agreement with theoretical predictions at next-to-next-to-leading order in the strong coupling. Based on a previous LHCb measurement of the ZZ boson production cross-section in ppPb collisions at sNN=5.02\sqrt{s_{NN}}=5.02 TeV, the nuclear modification factor RpPbR_{p\rm{Pb}} is measured for the first time at this energy. The measured values are 1.2−0.3+0.5 (stat)±0.1 (syst)1.2^{+0.5}_{-0.3}\,(\rm{stat}) \pm 0.1\,(\rm{syst}) in the forward region (1.53<yΌ∗<4.031.53<y^*_{\mu}<4.03) and 3.6−0.9+1.6 (stat)±0.2 (syst)3.6^{+1.6}_{-0.9}\,(\rm{stat}) \pm 0.2\,(\rm{syst}) in the backward region (−4.97<yΌ∗<−2.47-4.97<y^*_{\mu}<-2.47), where yΌ∗y^*_{\mu} represents the muon rapidity in the centre-of-mass frame.Comment: All figures and tables, along with any supplementary material and additional information, are available at https://cern.ch/lhcbproject/Publications/p/LHCb-PAPER-2023-010.html (LHCb public pages

    Studies of η\eta and ηâ€Č\eta' production in pppp and ppPb collisions

    Full text link
    The production of η\eta and ηâ€Č\eta' mesons is studied in proton-proton and proton-lead collisions collected with the LHCb detector. Proton-proton collisions are studied at center-of-mass energies of 5.025.02 and 13 TeV13~{\rm TeV}, and proton-lead collisions are studied at a center-of-mass energy per nucleon of 8.16 TeV8.16~{\rm TeV}. The studies are performed in center-of-mass rapidity regions 2.5<yc.m.<3.52.5<y_{\rm c.m.}<3.5 (forward rapidity) and −4.0<yc.m.<−3.0-4.0<y_{\rm c.m.}<-3.0 (backward rapidity) defined relative to the proton beam direction. The η\eta and ηâ€Č\eta' production cross sections are measured differentially as a function of transverse momentum for 1.5<pT<10 GeV1.5<p_{\rm T}<10~{\rm GeV} and 3<pT<10 GeV3<p_{\rm T}<10~{\rm GeV}, respectively. The differential cross sections are used to calculate nuclear modification factors. The nuclear modification factors for η\eta and ηâ€Č\eta' mesons agree at both forward and backward rapidity, showing no significant evidence of mass dependence. The differential cross sections of η\eta mesons are also used to calculate η/π0\eta/\pi^0 cross section ratios, which show evidence of a deviation from the world average. These studies offer new constraints on mass-dependent nuclear effects in heavy-ion collisions, as well as η\eta and ηâ€Č\eta' meson fragmentation.Comment: All figures and tables, along with machine-readable versions and any supplementary material and additional information, are available at https://lhcbproject.web.cern.ch/Publications/p/LHCb-PAPER-2023-030.html (LHCb public pages
    • 

    corecore